"Global 3D Cell Culture Market Research Report 2016" by OBRC, is an extensive study on present state of the 3D Cell Culture Market.
3D cell culture allows culturing of cells in a 3D environment. Adoption rate of 3D cell culture is high amongst research labs, hospitals, and pharmaceutical, biopharmaceutical & biotechnology companies for the forecasted period. Cell biologics, diseases associated to liver, cancer cell therapy are set to drive 3D cell culture market. New innovations in tissue engineering and 3D printing technology have supplemented organ harvesting and transplant. Cell based therapies in hospitals and diagnostic centres for oncology patient are set to propel 3D cell culture market for the forecasted period. Increasing rate of consumers in healthcare in North America and Europe, emerging markets like India and China, are projected to fuel the growth of 3D cell culture market.
Increasing cell based research and new innovations in cell culture are the factors driving 3D cell culture market for the forecasted period. Growing demand for organ transplantation and increasing research & development investments are the opportunities in 3D cell culture market for the forecasted period.
High investments for cell biology research and shortage of infrastructure for cell based research in emerging countries can impact 3D cell culture market for the forecasted period. Variation in 3D cell culture products is a major challenge for the 3D cell culture market.
The research report is segmented in terms of technology, applications, and end users. Technology segmented, is further sub segmented into with scaffold and without scaffold. Without scaffold technology segment is divided further into 3D bioreactors, 3D petri-dishes, 3D bio-printing, microfluidics and hanging drop plates. With scaffold technology segments is classified into solid structure scaffold, hydrogels/ECM and micro-patterned surfaces. Application segment is sub segmented into tissue engineering, cell based assay, oncology, in vivo applications of stem cells, 3D printing, and other applications. End user segment is classified into biotechnology and pharmaceutical industries, research laboratories, hospitals and diagnostic centres, and other end users. Biotechnology and pharmaceutical industries are the leading end user segment for 3D cell culture market for the forecasted period.
Some of the leading companies in 3D cell culture market are, Thermo Fisher Scientific Ltd., Corning Incoporated., Lonza A. G., Sigma-Aldrich Co. LLC., Hi Media Laboratories., Promocell GmBH., 3D Biotek LLC., Bell Brook Labs., Kurray Co. Ltd., and Global Cell Solutions. The report provides comprehensive information like company profile, sales, revenue, market share and contact information.
Joint ventures, agreements, partnerships, collaborations, expansion in different countries, and strengthening supply chain network with distributors are some of the strategies taken by pioneers in 3D cell culture market, to increase their global presence. Research & development investments are high with the urge to develop quality products. Pluristem Therapeutics on 15th April 2016 was granted patent by Japan Patent Office on 3D cell culture method for cell based therapies from placental cells against hematopoietic diseases caused by chemotherapy or failed transplants.
Small biotechnology firms with unique and differentiated assets are driving innovation in 3D cell culture market. Singapore based Genome Institute of Singapore and Alabama based Vivo Bioscience Inc., has partnered for a joint research towards precision oncology on 30th September 2016.
The research report analysed 3D cell culture market geographically. Region wise the report is segmented as North America, Europe, Asia Pacific, and Rest of the World.
North America is the largest 3D cell culture market followed by Europe. North American markets are driven by demand for organ transplants, increasing investment inn oncology research and favourable regulatory environment. Increasing research towards cell biology, biotechnology and oncology both at university and industrial levels are driving the growth of 3D Cell Culture market in Europe, for the forecasted period. UK is a major in Europe for 3D cell culture with increasing investments for cancer research.
Asia Pacific is the fastest growing market for 3D cell culture market. Increasing government investment in the area of cell biology and oncology research, growing talent pool towards cell biology research, and new regulatory reforms are the driving force behind 3D Cell culture market in Asia Pacific. China and India are the leading markets in Asia Pacific, with growing awareness of organ transplantation and increasing investment cancer research being the driving factors.